Aaron Kramer
Director Ejecutivo en Trygg Pharma AS .
Perfil
Aaron Kramer is currently the Chief Executive Officer at Trygg Pharma AS.
Previously, he was the President-Pharmaceutical at Aker BioMarine ASA in 2010.
He holds an MBA from Harvard University and an undergraduate degree from Tufts University.
Cargos activos de Aaron Kramer
| Empresas | Cargo | Inicio |
|---|---|---|
Trygg Pharma AS
 Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Trygg Pharma AS develops marine based omega-3 fatty acids for pharmaceutical applications. Its products consist of AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters; and AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters. The company was founded in 2009 and is headquartered in Oslo, Norway. | Director Ejecutivo | - |
Antiguos cargos conocidos de Aaron Kramer.
| Empresas | Cargo | Fin |
|---|---|---|
Aker BioMarine ASA
 Aker BioMarine ASA Agricultural Commodities/MillingProcess Industries Aker BioMarine ASA engages in the marine biotechnology industry. It develops and supplies biomarine ingredients to the animal, human nutrition, and pharmaceutical markets. Its core business is harvesting, production, sales and marketing of krill based products. The company was founded in 2006 and is headquartered in Oslo, Norway. | Director Financiero/CFO | 11/06/2010 |
Formación de Aaron Kramer.
| Tufts University | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Aker BioMarine ASA
Aker BioMarine ASA Agricultural Commodities/MillingProcess Industries Aker BioMarine ASA engages in the marine biotechnology industry. It develops and supplies biomarine ingredients to the animal, human nutrition, and pharmaceutical markets. Its core business is harvesting, production, sales and marketing of krill based products. The company was founded in 2006 and is headquartered in Oslo, Norway. | Process Industries |
Trygg Pharma AS
Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Trygg Pharma AS develops marine based omega-3 fatty acids for pharmaceutical applications. Its products consist of AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters; and AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters. The company was founded in 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Bolsa de valores
- Insiders
- Aaron Kramer
